null

Human Chemokine Array (38 targets) (SARB0030)

SKU:
SARB0030
Product Type:
Protein Array
Analytes:
BLC (CXCL13)
CCL28 (MEC)
Ck beta 8-1 (CCL23)
CTACK (CCL27)
CXCL16
ENA-78 (CXCL5)
Eotaxin-1 (CCL11)
Eotaxin-2 (MPIF-2/CCL24)
Eotaxin-3 (CCL26)
Fractalkine (CX3CL1)
GCP-2 (CXCL6)
GRO alpha/beta/gamma
GRO alpha (CXCL1)
HCC-4 (CCL16)
I-309 (TCA-3/CCL1)
I-TAC (CXCL11)
IL-8 (CXCL8)
IP-10 (CXCL10)
Lymphotactin (XCL1)
MCP-1 (CCL2)
MCP-2 (CCL8)
MCP-3 (MARC/CCL7)
MCP-4 (CCL13)
MDC (CCL22)
MIG (CXCL9)
MIP-1 alpha (CCL3)
MIP-1 beta (CCL4)
MIP-1 delta (CCL15)
MIP-3 alpha (CCL20)
MIP-3 beta (CCL19)
MPIF-1 (CCL23)
NAP-2 (PPBP/CXCL7)
PARC (CCL18)
RANTES (CCL5)
SDF-1 alpha (CXCL12 alpha)
SDF-1 beta (CXCL12 beta)
TARC (CCL17)
TECK (CCL25)
Reactivity:
Human
Applications:
Multiplex Array
$695 - $1,355
Frequently bought together:

Description

system_update_altDatasheet

Human Chemokine Array (38 targets) (SARB0030)

The Human Chemokine Array - 38 Targets (SARB0030) is a powerful research tool for studying the interactions and functions of chemokines in human samples. This array allows for the simultaneous detection of 38 different chemokines in a single experiment, providing valuable insights into the inflammatory and immune responses in various disease states.With its high sensitivity and specificity, this array is designed to accurately quantify the levels of different chemokines, allowing researchers to compare the expression profiles of multiple targets in a single assay. This comprehensive approach enables a deeper understanding of chemokine signaling pathways and their impact on cell migration, activation, and immune cell recruitment.

The Human Chemokine Array - 38 Targets (SARB0030) is ideal for researchers studying cytokine networks, inflammation, and immune responses in diseases such as cancer, autoimmune disorders, and infectious diseases. By analyzing the levels of multiple chemokines simultaneously, this array provides a more complete picture of the complex interplay between chemokines and immune cells, offering valuable insights for the development of novel therapeutic strategies.